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Background: Urinary tract infections (UTIs) are one of the most common bacterial infections with global
expansion. These infections are predominantly caused by uropathogenic Escherichia coli (UPEC).
Methods: Totally, 123 strains of Escherichia coli isolated from UTIs patients, using bacterial culture method
were subjected to polymerase chain reactions for detection of various O- serogroups, some urovirulence
factors, antibiotic resistance genes and resistance to 13 different antibiotics.
Results: According to data, the distribution of O1, O2, O6, O7 and O16 serogroups were 2.43%, besides O22,
O75 and O83 serogroups were 1.62%. Furthermore, the distribution of O4, O8, O15, O21 and O25 serogroups
were 5.69%, 3.25%, 21.13%, 4.06% and 26.01%, respectively. Overall, the fim virulence gene had the highest
(86.17%) while the usp virulence gene had the lowest distributions of virulence genes in UPEC strains isolated
from UTIs patients. The vat and sen virulence genes were not detected in any UPEC strains. Totally, aadA1
(52.84%), and qnr (46.34%) were the most prevalent antibiotic resistance genes while the distribution of cat1
(15.44%), cmlA (15.44%) and dfrA1 (21.95%) were the least. Resistance to penicillin (100%) and tetracycline
(73.98%) had the highest while resistance to nitrofurantoin (5.69%) and trimethoprim (16.26%) had the
lowest frequencies.
Conclusions: This study indicated that the UPEC strains which harbored the high numbers of virulence and
antibiotic resistance genes had the high ability to cause diseases that are resistant to most antibiotics. In
the current situation, it seems that the administration of penicillin and tetracycline for the treatment of UTIs
is vain.
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Urinary tract infections (UTIs) are one of the most fre-
quent infectious diseases around the world. Urinary tract
infections comprise ranges of disorders including pyelo-
nephritis (infection of the kidney) and cystitis (infection of
the bladder), which are defined by the presence of micro-
organisms in urinary tract [1]. Foxman (2003) indicated
that 40%-50% of women have UTIs throughout their lives
[2]. Also, previous report of WHO showed that the UTIs* Correspondence: hamomtaz@yahoo.com, hamomtaz@iaushk.ac.ir
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reproduction in any medium, provided the orare common causes of febrile illness in 3–8% of girls and
1% of boys [3].
Escherichia coli (E. coli) is the most important cause of
UTI [4,5]. Uropathogenic E. coli (UPEC) strains have
shown certain virulent properties, including iron uptake
systems, adhesins, specific O: K: H serotypes and synthesis
of cytotoxins. All of these properties contribute to
colonization and invasion of the bacterium [6]. The suc-
cessful colonization of UPEC in the urinary tract depends
on the expression of fimbrial adhesion proteins, which fa-
cilitate attachment of the bacterium to the urothelium,
and on the presence of specific bacterial genes that encode
virulence factors [7-9].l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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serological typing of their H (flagellar), O (lipopolysacchar-
ide) and in some cases, K (capsular) surface antigens.
Overall, 174 O-serogroups are described for E. coli [10].
The O-serogroups of UPEC strains are related to certain
virulence factor profile of each strain. Previous studies
reported that O1, O2, O4, O6, O7, O8, O15, O16, O18,
O21, O22, O25, O75 and O83 serogroups are preferentially
associated with UPEC strains [11-18].
Some of the most important virulence genes of UPEC
strains which are associated with severe UTIs are aero-
bactin (aer), P fimbriae (pap), type 1 fimbriae, afimbrial
adhesin I (afaI), hemolysin (hly), cytotoxic necrotizing fac-
tor 1 (cnf 1), aerobactin (aer), S fimbriae (sfa), adhesins and
fimbriae [19,20]; however, other virulence genes such as
kpsMT, ompT, usp, iroN, iha, set 1, astA, group II capsule
synthesis; sfa/foc, S and F1C fimbriae; iutA, traT, serum re-
sistance; and fimH, are known to be involved in pathogen-
icity of this organism [21-23].
The treatment of diseases caused by this bacterium often
requires antimicrobial therapy; however, antibiotic-resistant
strains of bacteria cause more severe diseases for longer pe-
riods of time than their antibiotic-susceptible counterparts.
Several studies showed that antibiotic resistance in UPEC is
increasing nowadays [24,25]. Because of the high antimicro-
bial resistances of UPEC strains in Portugal (26%), Italy
(25%) and Spain (21%) [26], the identification of bacterial
resistance genes seems to be essential to reduce the treat-
ment costs. To our knowledge, the epidemiology and
prevalence of serogroups, virulence factors and antimicro-
bial resistance properties of UPEC strains isolated from
patients with UTIs are unknown in Iran. So, the current
survey was carried out in order to determine the sero-
groups, virulence factors and antimicrobial resistance prop-
erties of UPEC strains isolated from patients with UTIs
in Iran.Methods
Bacterial strains
A total of 123 E. coli strains isolated from patients with
symptomatic UTIs were enrolled in the current investiga-
tion. The patients were hospitalized or visited the emer-
gence room at Baqiyatallah Hospital in Tehran, Iran. The
strains were isolated from pure cultures and identified in
the laboratory of Molecular Biology Research Center at
Hospital. The strains which were biochemically confirmed
as E. coli- positive, were kept in Luria-Bertani /glycerol
at −70°C.DNA isolation
Bacterial strains were subcultured overnight in Luria-
Bertani broth (Merck, Germany) and genomic DNA was
extracted from typical colonies of E. coli using DNAextraction kit (DNP™, CinnaGen, Iran) according to
manufacturer’s instruction.
Detection of uropathogenic E. coli serogroups, virulence
factors and antibiotic resistance genes
In the present study various PCR assays were used for
detection of serogroups, virulence factors and antimicro-
bial resistance genes of UPEC E. coli isolates. Table 1
showes the primers applied for detection of UPEC viru-
lence genes, Table 2 indicates the primers used for de-
tection of UPEC serogroups and finally in Table 3 the
primers used for detection of antimicrobial resistant
genes in uropathogenic E. coli are shown. The amplified
products were visualized by ethidium bromide staining
after gel electrophoresis of 10 μL of the final reaction
mixture in 1.5% agarose.
Antimicrobial susceptibility testing
Antimicrobial susceptibility tests was performed by the
Kirby–Bauer disc diffusion method using Mueller–Hinton
agar (HiMedia Laboratories, Mumbai, India, MV1084),
according to the Clinical and Laboratory Standards Insti-
tute guidelines [40]. After incubating the inoculated plates
aerobically at 37°C for 18–24 h in an aerobic atmosphere,
the susceptibility of the E. coli isolates to each antimicro-
bial agent was measured and the results were interpreted
in accordance with interpretive criteria provided by CLSI
(2006). E. coli ATCC 25922 was used as quality control
organisms in antimicrobial susceptibility determination.
Statistical analysis
The data were analyzed using SPSS software (Version 17.
SPSS Inc, United States) to find any significant correlation
between incidences of virulence factors and antibiotics re-
sistance genes of uropathogenic E. coli serogroups isolated
from patients with urinary tract infection. Statistical sig-
nificance was regarded at a P value < 0.05.
Ethical issues
In the current study we tried to protect the life, health,
dignity, integrity, rights to self-determination, privacy,
and confidentiality of personal information of research
subjects. We conform to generally accepted scientific
principles, be based on a thorough knowledge of the
scientific literature, other relevant sources of informa-
tion, and adequate laboratory and, as appropriate, animal
experimentation. All samples were taken from volunteer
patients for this research. All ethical issues were consid-
ered and this research was performed with hospitals’
permission. The name and characters, personal informa-
tion and even patients’ illnesses and their medical infor-
mation remained secret. In addition, in this cooperation
agreement we stated that this research will help urology
and microbiology and is able to clarify the epidemiology
Table 1 Primers used for detection of virulence genes in uropathogenic Escherichia coli
Gene Primer name Primer sequence (5'-3') Size of product (bp) Reference
set-1 set-1-F GTGAACCTGCTGCCGATATC 147 [21]
set-1-R ATTTGTGGATAAAAATGACG
sen Sen-F ATGTGCCTGCTATTATTTAT 799 [21]
Sen-R CATAATAATAAGCGGTCAGC
astA astA-F ATGCCATCAACACAGTATAT 110 [21]
astA-R GCGAGTGACGGCTTTGTAGT
sigA sigA-F TCCTCGGTATTATTTTATCC 408 [21]
sigA-R CGTAACCCCTGTTGTTTCCAC
sap Sap_f TACCCTCCACAACAGAGAATG 832 [21]
Sap-R TACCCTCCACAACAGAGAATG
pic Pic-F ACTGGATCTTAAGGCTCAGGAT 500 [21]
Pic-R GACTTAATGTCACTGTTCAGCG
pap pap3 GCAACAGCAACGCTGGTTGCATCAT 336 [27]
pap4 AGAGAGAGCCACTCTTATACGGACA
cnf1 cnf1 AAGATGGAGTTTCCTATGCAGGAG 498 [27]
cnf2 TGGAGTTTCCTATGCAGGAG
hlyA hly1 AACAAGGATAAGCACTGTTCTGGCT 1177 [27]
hly2 ACCATATAAGCGGTCATTCCCGTCA
sfa sfa1 CTCCGGAGAACTGGGTGCATCTTAC 410 [28]
sfa2 CGGAGGAGTAATTACAAACCTGGCA
afa afa1 GCTGGGCAGCAAACTGATAACTCTC 750 [28]
afa2 CATCAAGCTGTTTGTTCGTCCGCCG
iuc iuc1 ATGAGAATCATTATTGACATAATTG 1482 [29]
iuc2 CTCACGGGTGAAAATATTTT
fim fim1 GAGAAGAGGTTTGATTTAACTTATTG 559 [30]
fim2 AGAGCCGCTGTAGAACTGAGG
papGI papGJ96-F TCGTGCTGAGGTCCGGAATTT 461 [31]
papGJ96-R TGGCATCCCCCAACATTATCG
papGII papGIA2-F GGGATGAGCGGGCCTTTGAT 190 [31]
papGIA2-R CGGGCCCCCAAGTAACTCG
papGIII prsJ96-F GGCCTGCAATGGATTTACCTGG 258 [31]
prsJ96-R CCACCAAATGACCATGCCAGAC
kpsMT kpsM481F CCATCGATACGATCATTGCACG 400 [32]
kpsM481R ATTGCAAGGTAGTTCAGACTCA
iha IHA-F CTGGCGGAGGCTCTGAGATCA 827 [23]
IHA-R TCCTTAAGCTCCCGCGGCTGA
iron IRONEC-F AAGTCAAAGCAGGGGTTGCCCG 665 [23]
IRONEC-R GACGCCGACATTAAGACGCAG
ompT ompT-F ATCTAGCCGAAGAAGGAGGC 559 [33]
ompT-R CCCGGGTCATAGTGTTCATC
usp usp -F ACATTCACGGCAAGCCTCAG 440 [22]
usp -R AGCGAGTTCCTGGTGAAAGC
iss Iss-F ATCACATAGGATTCTGCCG 309 [34]
Iss-R CAGCGGAGTATAGATGCCA
irp2 Irp2-F AAGGATTCGCTGTTACCGGAC 413 [34]
Irp2-R AACTCCTGATACAGGTGGC
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Table 1 Primers used for detection of virulence genes in uropathogenic Escherichia coli (Continued)
tsh Tsh-F ACTATTCTCTGCAGGAAGTC 824 [34]
Tsh-R CTTCCGATGTTCTGAACGT
vat Vat-F TCCTGGGACATAATGGTCAG 981 [34]
Vat-R GTGTCAGAACGGAATTGT
cva Cva-F TGGTAGAATGTGCCAGAGCAAG 1181 [34]
Cva-R GAGCTGTTTGTAGCGAAGCC
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microbial resistance of UPEC strains isolated from pa-
tients with urinary tract infection. All of the patients
showed their satisfaction in order to use their sample in
this investigation especially to determine antibiotic re-
sistance in UPEC strains.Table 2 Primers used for detection of uropathogenic Escheric





























E. coli 16SrRNA wl-3110
wl-3111Results and discussion
Our results revealed high distribution of UPEC
serogroups isolated from patients with urinary tract in-
fection (Table 4). Totally, O25 (26.01%), O15 (21.13%)
and O16 (10.56%) had the highest while O18 (0.81%),
O75 (1.62%), O22 (1.62%) and O83 (1.62%) had thehia coli serogroups [35]































Table 3 Primers used for detection of antimicrobial resistant genes in uropathogenic Escherichia coli
Antimicrobial agent Resistance gene Sequence Size (bp) References
Streptomycin aadA1 (F) TATCCAGCTAAGCGCGAACT 447 [36]
(R) ATTTGCCGACTACCTTGGTC
Gentamicin aac(3)-IV (F) CTTCAGGATGGCAAGTTGGT 286 [36]
(R) TCATCTCGTTCTCCGCTCAT
Sulfonamide sul1 (F) TTCGGCATTCTGAATCTCAC 822 [36]
(R) ATGATCTAACCCTCGGTCTC
Beta-lactams blaSHV (F) TCGCCTGTGTATTATCTCCC 768 [36]
(R) CGCAGATAAATCACCACAATG
Beta-lactams CITM (F) TGGCCAGAACTGACAGGCAAA 462 [36]
(R) TTTCTCCTGAACGTGGCTGGC
Chloramphenicol cat1 (F) AGTTGCTCAATGTACCTATAACC 547 [36]
(R) TTGTAATTCATTAAGCATTCTGCC
Chloramphenicol cmlA (F) CCGCCACGGTGTTGTTGTTATC 698 [36]
(R) CACCTTGCCTGCCCATCATTAG
Tetracycline tet(A) (F) GGTTCACTCGAACGACGTCA 577 [37]
(R) CTGTCCGACAAGTTGCATGA
Tetracycline tet(B) (F) CCTCAGCTTCTCAACGCGTG 634 [37]
(R) GCACCTTGCTGATGACTCTT
Trimethoprim dfrA1 (F) GGAGTGCCAAAGGTGAACAGC 367 [38]
(R) GAGGCGAAGTCTTGGGTAAAAAC
Quinolones qnr (F) GGGTATGGATATTATTGATAAAG 670 [39]
(R) CTAATCCGGCAGCACTATTTA
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patients with UTIs (Table 4). Besides, the serogroups of
13.82% UPEC strains isolated from these patients could
not be detected and were diagnosed as non-detected
serogroups (Table 4).
Overall, fim and set1 had the highest distributions of viru-
lence genes while usp, kpsMT, cva and ompT had the low-
est (Table 4). As it was shown in Table 4, we were not able
to identify the distributions of sen and tsh virulence genes
of UPEC in our population. Table 5 shows the distributions
of antibiotic resistance genes of UPES isolated from pa-
tients with UTIs. It was recognized that aadA1 (52.84%)
and qnr (46.34%) had the highest while cat1 (15.44%) and
cmlA (15.44%) had the lowest distributions of antibiotic
resistance genes (Table 5). Also, the distributions of tetA,
tet B, dfrA1, dfrA1, aac(3)-IV, sul1, blaSHV and CITM
antibiotic resistance genes were 43.80%, 36.58%, 21.95%,
22.76%, 36.58%, 27.64% and 39.83%, respectively (Table 5).
The disk diffusion method indicated that the UPEC
serogroups had maximum resistance to penicillin (100%)
and tetracycline (73.98%) antibiotics while resistance to
nitrofurantoin (5.69%) was minimum (Table 6). Besides, the
UPEC serogroups had 53.65%, 25.20%, 30.89%, 33.33%,
29.26%, 20.32% and 36.58% resistances to streptomycin,
chloramphenicol, sulfamethoxazol, enrofloxacin, enroflo-
xacin, lincomycin, cephalothin and ampicillin antibiotics,respectively. Totally, resistance to gentamycin, ciprofloxacin
and trimethoprim were minimal (17.07%, 19.51% and
16.26%), respectively (Table 6).
Our results revealed that the UPEC strains were able to
be one of the major causative agents of UTIs in Iran and
this finding was in accordance with the previous study
which mentioned that 150 million people are diagnosed as
UTI- positive annually [41]. Also, The UPEC strains are iso-
lated from the uterine contents in the majority (82–100%)
of clinical pyometra cases [42,43]. Therefore, such a high
prevalence of serogroups, virulence factors and antibiotic
resistance genes in UPEC strains exhibits that there is a
high risk of developing incurable diseases.
Several investigations have been performed on the
prevalence of UPEC strains in UTI cases in Iran [44,45].
Kalantar et al. [44] showed that the E. coli was the most
frequent occurring pathogen (54.80%) in patients with
severe UTIs. Esmaeili [45] demonstrated that the E. coli
was the most common cause of UTI in human. Also,
previous study has been reported that the incidence of
UTI has been increased recently [46].
Another study in Iran showed that 140 out of 244 pa-
tients with UTIs (57.37%) had the high levels of E. coli
infection which was lower than our percentage (66.12%)
[47]. Ghorashi et al. [48] declared that 77% of patients
with UTIs were positive for E. coli which was higher
Table 4 Distribution of virulence genes in uropathogenic Escherichia coli serogroups isolated from urinary tract infections in Iran
Gene O1 (3) O6 (13) O7 (3) O8 (4) O16 (3) O21 (5) O75 (2) O2 (3) O4 (7) O15 (26) O18(1) O22 (2) O25 (32) O83 (2) Non detect (17)
set1 (98) 3 12 3 4 3 3 - 1 4 25 - 2 28 - 10
astA (26) - 3 1 1 - 1 - - - 8 - - 10 - 2
sigA (26) 1 5 - - 1 - 1 1 1 - 1 1 11 1 2
sap (32) - - - 3 2 1 - - 1 10 1 - 14 - -
pic (16) 2 8 1 - - - 1 - - 4 - - - - -
sfa (66) 1 8 1 - 3 4 1 2 5 10 1 - 23 - 7
afa (10) - - - - - - 1 - - 3 - - 4 - 2
cnf1 (62) 1 4 - 2 1 4 - - 4 15 1 - 30 - -
hlyA (62) - 8 2 - - 2 - 2 4 21 - 1 9 1 10
iuc (13) - - - - - - - - - 3 - - 10 - -
fim (106) 3 10 3 3 1 5 2 3 7 23 1 2 30 2 11
kspMT (5) - 1 - 1 - - - 1 - 2 - - - -
ompT (6) - - - - - - - 1 - 1 - - 3 - 1
usp (2) - - - - - - - - - 1 - - - - 1
iss (10) - 2 - - - 1 - - 2 3 - - 2 - -
irp2 (14) - - - - 1 - - - - 1 - - 10 - 1
vat (12) 1 - 1 2 - - 1 2 - - 1 - 3 1 -
cva (6) - 6 - - - - - - - - - - - - -
pap (62) 1 3 1 2 1 3 1 1 4 20 - 1 20 1 3
papGI (10) - 1 1 - - 1 - - - 4 - 1 - 1 1
papGII (19) - - - - - - 1 1 4 3 - - 8 - 2
papGIII (62) 1 2 1 2 1 2 1 1 2 19 - - 19 - 11
iha (22) - 2 - 1 - 1 - - - 3 1 1 10 1 2

























Table 5 Distribution of antimicrobial resistance genes in uropathogenic Escherichia coli serogroups isolated from urinary tract infections in Iran
UPEC Serogroup Antibiotic resistance genes
aadA1 tetA tetB dfrA1 qnr aac(3)-IV sul1 blaSHV CITM cat1 cmlA
O1 (3) 1 1 1 1 1 1 1 1 1 - -
O6 (13) 6 6 3 4 5 1 11 7 7 1 1
O7 (3) 1 - 2 2 2 1 2 - 2 - -
O8 (4) 1 2 - 2 - 1 1 1 2 - -
O16 (3) 2 1 1 1 - 1 1 1 3 1 -
O21 (5) - 3 2 1 2 2 1 1 - 1 1
O75 (2) 1 1 1 1 - 1 - 2 1 - 1
O2 (3) 1 2 1 1 1 1 2 2 - 2 -
O4 (7) 1 4 2 - 6 4 - 3 2 2 1
O15 (26) 8 10 9 11 6 10 10 4 10 - 1
O18 (1) - - 1 1 1 2 1 - - 1 -
O22 (2) 1 1 - 1 - 1 1 2 1 - -
O25 (32) 31 18 14 1 28 1 1 1 17 10 14
O83 (2) 1 - - - 3 1 2 2 2 - -
Non detected (17) 10 4 8 - 2 - 11 7 1 1 -

























Table 6 Antimicrobial resistance properties in uropathogenic Escherichia coli serogroups isolated from urinary tract infections in Iran
UPEC Serogroup P10 (%) TE30 (%) S10 (%) C30 (%) SXT (%) GM10 (%) NFX5 (%) L2 (%) CF30 (%) CIP5 (%) TMP5 (%) F/M300 (%) AM10 (%)
O1 (3) 3 2 2 - 1 - - 1 - - 1 - 1
O6 (13) 13 8 6 2 10 1 2 10 6 5 4 2 6
O7 (3) 3 - 2 - 2 1 2 1 - - 1 - 2
O8 (4) 4 2 2 - 1 1 - 1 - - 1 - 2
O16 (3) 3 2 1 - - - - 1 - - 1 - 2
O21 (5) 5 4 2 1 1 1 1 1 - 2 - 1 -
O75(2) 2 2 - 1 - - - - 1 - - - 1
O2 (3) 3 3 - 2 1 - - - 1 - - 1 -
O4(7) 7 6 5 2 - 4 1 2 3 6 - - 2
O15 (26) 26 19 14 - 10 10 6 15 4 5 10 1 10
O18 (1) 1 - - 1 - 1 - - - - 1 - -
O22 (2) 2 1 - - 1 1 - - 2 - 1 - 1
O25 (32) 32 30 18 22 - 1 27 4 - 6 - - 17
O83 (2) 2 - - - 1 - 2 - 1 - - - 1
Non detected (17) 17 12 14 - 10 - - - 7 - - 2 -
Total (123) 123 (100%) 91 (73.98%) 66 (53.65%) 31 (25.20%) 38 (30.89%) 21 (17.07%) 41 (33.33%) 36 (29.26%) 25 (20.32%) 24 (19.51%) 20 (16.26%) 7 (5.69%) 45 (36.58%)
In this table P10 = penicillin (10 u/disk); TE30 = tetracycline (30 μg/disk); S10 = streptomycin (10 μg/disk); C30 = chloramphenicol (30 μg/disk); SXT = sulfamethoxazol (25 μg/disk); GM10 = gentamycin (10 μg/disk);
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formed on the prevalence of UPEC strains in UTI cases
around the world including Brazil [49], United States [50],
Europe, and Canada [51].
Our results indicated that there were several serogroups
of E. coli in UTI positive patients. There was statistical
significant differences between the presence of O25 and
O18 serogroups (P < 0.01), O25 and O83, O75, O22, O7,
O2 and O1 (P < 0.05). Totally, O25 and O15 were the most
prevalent serogroups. Since 1980 [52], many investigators
reported that several O-serogroups were found with vari-
able frequencies in UTIs patients. Similar results have been
reported recently too [12,53]. The previous survey showed
that the majority of uropathogenic E. coli strains such as
O4, O6, O14, O22, O75 and O83 were HlyA +CNF1+ and
expressed P-fimbriae or MRHA type III, whereas O18
serogroup strains were HlyA +CNF1− and P-fimbriated
[14] which was in accordance with those of us.
Based on our results, there were significant differences
about (P < 0.01) between the presence of fim, tsh and
sen virulence genes as well as set1, tsh and sen genes
(P < 0.05) and also between fim and usp genes of isolated
E. coli strains (P < 0.05). Therefore, fim and set1 were
the most common virulence genes. Arabi et al. [54]
showed the similar results of UPEC virulence genes
in Iran. Arabi et al. [54] indicated that the fim and sfa
fimbriae genes were observed in 92.7% of isolates, sepa-
rately. Also, Asadi Karam et al. [55] showed that the fim
genes were the most prevalent virulence genes of UPES
strains. Karimian et al. [56] proved that fimH gene with
the frequency rate of 79.67% was the most and tsh and
usp genes with the frequency rate of 0.0% and 1.62%
respectively were the least common virulence genes in
E. coli strains isolated from patients with urinary tract
infections. Also, Karimian et al. [56] showed that the
presence of cnf1, hlyA, pap, iroN, afa, iuc, iha, ompT
and irp2 virulence genes were 50.4, 50.4, 50.4, 42.27,
8.13, 10.56, 17.88, 4.87 and 11.38%, respectively. Other
virulence genes of UPEC strains like aatA, aggR and
stbA [47] and stx1 and stx2 [57] have been reported
from Iran previously. Another investigation announced
that the prevalence rate of fimH, fyuA, kpsMTII and
iucD genes were above 75% likewise papC, papG, sat,
iron, usp and traT were between 35-65% [12].
Our results contrary to other studies indicated that
there are the possibilities of the existence of multiple
virulence genes in UPEC strains isolated from UTIs pa-
tients [58,59]. The importance of UPEC strains’ sfa gene
in patients with severe UTIs has been reported previ-
ously [59,60] while Abe et al. [11] and Santo et al. [59]
reported lower prevalence of sfa gene among UPEC. An-
other study indicated that usp and iha virulence genes
were present in 63.7% and 34.1% of all E. coli isolates
[22] which both were higher than our findings.The statistical analyses were significant among aadA1,
cat1 and cmlA antibiotic resistance genes (P < 0.05). This
correlation was demonstrated among tetracycline and
nitrofuration (P < 0.05) and also penicillin, trimethoprim
and gentamycin (P < 0.05) too. High frequency of resis-
tant UPEC strains to one or more antimicrobials was ob-
served in the present work and it was in agreement with
previous studies [61,62].
The most common antibacterial drugs in UTIs’ treatment
are trimethoprim-sulfamethoxazole, cephalosporins, semi-
synthetic penicillins with or without beta-lactamase inhibi-
tors and quinolones [62,63]; however, our results proved
that resistance to penicillin, sulfamethoxazole, trimethoprim
and cephalotin were 100%, 30.89%, 16.26% and 20.32%, re-
spectively. Oliveira et al. from Brazil [61] reported that 90%
of UPEC strains possessed at least one of the resistant
genes, the prevalence of them were as follows: traT (76%),
aer (41%), PAI (32%), sfa (26%), pap (25%), cnf1 (18%), afa
(6%), and hly (5%) and the most common were ampicillin
(51%) and trimethoprim-sulfamethoxazole (44%). Accord-
ing to Idrees Muhammad et al. [64] results, there were high
prevalence of class 1 integrons (43.56%), sulfamethoxazole
resistance genes sul1 (45.54%) and sul2 (51.48%) as well as
quinolone resistance genes in multi drug resistance UPEC
isolates in Pakistan. Farshad et al. [65] showed the high
prevalence of resistance genes to ampicillin (80.2%), co-
trimoxazole (76%) and tetracycline (70.8%) in Iran.
Recently, trimethoprim-sulfamethoxazole was used as
a standard antibiotic for a calculated UTIs therapy and
due to the increased resistance of UPEC strains to this
class of antibiotics, fluoroquinolones as broad-spectrum
antimicrobial agents have been used with increasing fre-
quency in complicated as well as uncomplicated UTIs
[66], but after a short time resistance to fluoroquinolones
was emerged [67]. Previous study showed that more than
10% of the E. coli isolated in 2000–2002 from intensive
care unit patients in European and North American were
resistant to ciprofloxacin [68], while this amount of resis-
tance was increased significantly in our evaluation.
Gulsun et al. [69] reported that the sensitivity of the
UPEC strains to the norfloxacin, ciprofloxacin, netil-
micin, amikacin, ceftriaxone, gentamicin, nitrofurantoin,
amoxicillin-clavulanate, trimethoprim/sulfamethoxazole
and ampicillin were 89%, 85%, 80%, 78%, 74%, 72%,
71%, 58%, 45%, 35%, respectively which was somewhat
similar to our progeny. In a study carried out in India,
the highest resistance have been shown against amoxicil-
lin (67.3%) and least against nitrofurantoin (57.3%) [70]
which was similar to our findings. On the other hand
our results revealed that in the current situations the
nitrofurantoin is a choice drug due its lowest antibiotic
resistance in UPEC strains. Eighty five to ninety two per-
cent of UPEC strains were sensitive to nitrofurantoin in
previous study [53].
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was 25.5% but chloramphenicole is a forbidden antibiotic
and the high antibiotic resistance to this drug in our study
indicated the irregular and unauthorized use of this drug in
medicine treatments. Unfortunately, not only in medicine,
but also veterinarians in many fields of veterinary such as
large animal internal medicine, poultry and even aquacul-
ture, use this antibiotic as a basic one. Therefore, in a very
short period of time, antibiotic resistance will appear.
Conclusions
Based on our results, O25 serotype, fim virulence gene,
aadA1 antibiotic resistance gene and finally resistance to
penicillin had highest frequencies in UPEC strains isolated
from UTIs patients. The results of our study revealed the
high presence of UPEC strains in patients with UTIs in
Iran. To our knowledge, our study is the first report of di-
rect detection of serogroups, virulence factors and anti-
microbial resistance properties of uropathogenic E. coli
strains in Iran. Due to the high prescription of antibiotics in
humans and even animals, antibiotics resistance has been
increased in UPEC strains and we recommend using antibi-
otics only in severe conditions and applying strong antibi-
otics and multi antibiotic descriptions.
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